Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol

Digestive Diseases and Sciences

Volumn 50, Issue 6, 2005, Pages 1046-1051

  Zhang, Hongjun ^a   Tang, Javon ^b   Meng, Xangwen ^a   Tsang, Jackie ^c   Tsang, Tat Kin ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d EVANSTON HOSPITAL   (United States)

Author keywords

Bacteria; Biliary; Bismuth dimercaprol; Stent

Indexed keywords

BISMUTH 2, 3 DIMERCAPTOPROPANOL; BISMUTH DERIVATIVE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BILE; BIOFILM; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG USE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; KLEBSIELLA PNEUMONIAE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SPECIES; STENT; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BILE; BIOFILMS; DIMERCAPROL; DRUG COMBINATIONS; ENTEROBACTERIACEAE; ENTEROCOCCUS; EQUIPMENT CONTAMINATION; ORGANOMETALLIC COMPOUNDS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; STENTS; SWINE;

EID: 20844431709     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2702-x     Document Type: Article

References (31)

1. Speer AG, Cotton PB, Rode J, et al.: Biliary stent blockage with bacterial biofilm: a light and electron microscopy study. Ann Intern Med 108(4):546-553, 1988
2. Wosiewitz U, Schrameyer B, Safrany L: Biliary sludge: its role during bile drainage with an endoprosthesis. Gastroenterology 88:1706, 1985
3. Sung JY, Leung JW, Shaffer EA, Lam K, Costerton JW: Bacterial biofilm, brown pigment stone and blockage of biliary stents. J Gastroenterol Hepatol 8(1):28-34, 1993
4. Moesch C, Sautereau D, Cessot F, et al.: Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses. Hepatology 14(6):1142-1146, 1991
5. Leung JW, Libby ED, Morck DW, et al.: Is prophylactic ciprofloxacin effective in delaying biliary stent blockage? Gastrointest Endosc 52(2):175-182, 2000
6. Rees EN, Tebbs SE, Elliott TS: Role of antimicrobial-impregnated polymer and Teflon in the prevention of biliary stent blockage. J Hosp Infect 39(4):323-329, 1998
7. Leung JW, Lau GT, Sung JJ: Decreased bacterial adherence to silver-coated stent material: An in vitro study. Gastrointest Endosc 38(3):338-340, 1992
8. Tillman LA, Drake FM, Dixon JS. Wood JR: Review article: safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol Ther 10(4):459-467, 1996
9. Kappstein I, Engels I: Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid: Eur J Clin Microbiol 6(2):216-217, 1987
10. De Boer WA: Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection. Eur J Gastroenterol Hepatol 11(7):697-700, 1999
11. Coelho LG, Passos MC, Chausson Y, Castro L de P: Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse. Am J Gastroenterol 86(8):971-975, 1991
12. Farthing MJ: Review article: prevention and treatment of travellers' diarrhoea. Aliment Pharmacol Ther 5(1):15-30, 1991
13. Domenico P, Salo RJ, Novick SG, Schoch PE, Van Horn K, Cunha BA: Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrob Agents Chemother 41(8):1697-1703, 1997
14. Domenico P, Tomas JM, Merino S, Rubires X, Cunha BA: Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide. Infect Immun 67(2):664-669, 1999
15. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA: Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob Agents Chemother 45(5):1417-1421, 2001
16. Huang CT, Stewart PS: Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment. J Antimicrob Chemother 44(5):601-605, 1999
17. Chodash HB, Tsang TK, Pollack JM, Eisenman RE, Rege RM, Ostrow JD: Effect of temperature on stability of eight components of porcine gallbladder bile. Dig Dis Sci 42(2):273-278, 1997
18. Howard PJ, Murphy GM, Dowling RH: Gallbladder emptying patterns in response to a normal meal in healthy subjects and patients with gallstones: ultrasound study. Gut 32:1406-1411, 1991
19. Zhang HJ, Tsang TK, Jack CA: Bile glycoprotein mucin in sludge occluding biliary sent. J Lab Clin Med 142(1):58-61, 2003
20. Molinari G, Pugliese V, Schito GC, Guzman CA: Bacteria involved in the blockage of biliary stents and their susceptibility to antibacterial agents. Eur J Clin Microbiol Infect Dis 15(1):88-92, 1996
21. Zhang HJ, Tsang TK, Jack CA, Pollack JM: Role of bile mucin in bacterial adherence to biliary stent. J Lab Clin Med 139(1):28-34, 2001
22. Flores C, Maguilnik I, Hadlich E, Goldani LZ: Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol 18(3):333-336, 2003
23. Baldassarri L, Simpson WA, Donelli G, Christensen GD: Variable fixation of staphylococcal slime by different histochemical fixatives. Eur J Clin Microbiol Infect Dis 12(11):866-868, 1993
24. Torsoli A: Physiology of the human sphincter of Oddi. Endoscopy 20:166-170, 1998
25. Sung JY, Costerton JW, Shaffer EA: Defense system in the biliary tract against bacterial infection. Dig Dis Sci 37(5):689-696, 1992
26. Sung JY, Leung JW, Shaffer EA, Lam K, Costerton JW: Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 7(3):240-245, 1992
27. Pederson FM, Lassen AT, de Muckadell OBS: Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc 48:574-579, 1998
28. An YH, Friedman RJ: Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res 43(3):338-348, 1998
29. Costerton JW, Cheng KJ, Geesey GG, et al.: Bacterial biofilms in nature and disease. Annu Rev Microbiol. 41:435-464, 1987
30. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilm: A commom cause of persistent infections. Science 284:1318-1322, 1999
31. Wu CL, Domenico P, Hassett DJ, Beveridge TJ, Hauser AR, Kazzaz JA: Subinhibitory bismuth-thiols reduce virulence of Pseudomonas aeruginosa. Am J Resp Cell Mol Biol 26(6):731-738, 2002